Therapeutic Landscape of FOXM1 in Triple-Negative Breast Cancer and Aggressive Solid Cancers
Sayra Dilmaç(Houston Methodist), Bülent Özpolat(The University of Texas MD Anderson Cancer Center)
Cited by 13
Related Papers
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer
|Cell Death and Disease|2014|257
Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
|PLoS ONE|2012|118
The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells
|International Journal of Oncology|2015|114